Major pharma company acquires catnip repellent startup by 2028
Resolves: A pharmaceutical company announces an acquisition, merger, or exclusive licensing agreement with the team behind the catnip repellent technology
user-generated· adoption
Major pharma company acquires catnip repellent startup by 2028
Market overview
Given the low-cost and high efficacy of catnip repellents, a large pharmaceutical company will acquire or license the technology from Ugandan researchers to scale commercial production globally.
adoption prediction market
- Implied probability (Yes)
- 68%
- Closes
- 2028-03-31
About this prediction
Resolution criteria
A pharmaceutical company announces an acquisition, merger, or exclusive licensing agreement with the team behind the catnip repellent technology
Source: user-generated
More adoption markets
- Daily active crypto users surpass 100 million by mid-2026 — 60% Yes
- Kalshi’s market share in crypto derivatives surpasses 5% by Q4 2027 — 55% Yes
- Kalshi's crypto perpetual futures launch by 2026-Q4 — 75% Yes
- Family offices double down on crypto-adjacent mining firms within 6 months — 72% Yes
- Nigeria's crypto transaction volume exceeds $5B in 2026 — 80% Yes
- AI and crypto groups increase political ad spending in 2026 midterms — 80% Yes
- Crypto and AI groups double political ad spending by 2027 — 75% Yes
- Crypto billionaire Harborne will increase donations to Farage by 20% by Mar 2027 — 60% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…